If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca B Regulatory News (SVCT)

Share Price Information for Seneca B (SVCT)

Share Price is delayed by 15 minutes
Get Live Data
44.00    0.00 (0.00%)
Bid:
43.00
Ask:
45.00
Spread: 2.00 (4.651%)
Market Cap: £14.56m
SVCT Live PriceLast checked at - London Stock Exchange

Intraday Seneca B Share Chart

Issue of Equity and Total Voting Rights

8 Aug 2025 16:05

RNS Number : 6679U
Seneca Growth Capital VCT PLC
08 August 2025
 

Seneca Growth Capital VCT Plc (the "Company")

8 August 2025

 

Issue of Equity and Total Voting Rights

The Company announces that it has today allotted and issued 9,938 new B ordinary shares of 1p each in the Company ("B Shares").

The shares were issued pursuant to an offer for subscription for B Shares launched on 12 September 2024 to raise, in aggregate, up to £5 million with an over-allotment facility of up to a further £5 million (before issue costs) (the "Offer").

Pursuant to the Offer, and the £5,000 of valid applications received since 6 May 2025 (the cut-off date for the last allotment of shares made on 7 May 2025), and up to and including 7 August 2025 in respect of the 2025/2026 tax year, the Company has today allotted and issued 9,938 B Shares. In accordance with the allotment formula set out in the prospectus for the Offer, the B Shares have been allotted at the offer price of 50.3p per share, calculated by reference to the unaudited net asset value of a B Share as at 31 March 2025 (49.8p per B Share as announced on 3 April 2025).

As a result of this allotment, the number of shares now in issue is 8,115,376 ordinary shares of 1p each and 25,183,534 B Shares. Therefore, the total number of voting rights in the Company is 33,298,910.

In respect of this allotment, an application will be made by the Company to the Financial Conduct Authority and to the London Stock Exchange for the B Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the B Shares will become effective and dealings will commence on or around 18 August 2025.

The above statement of voting capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Offer is now closed to further applications. The Company announces that under the Offer it received and accepted valid applications to the value of £1,123,613.25 (before issue costs).

Shareholders can expect the Company to announce its unaudited interim results for the six months ended 30 June 2025 in September 2025.

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a regulatory information service, this information is considered to be in the public domain.

For further information, please contact:

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

Siobhan Pycroft, Seneca Partners Limited at Siobhan.Pycroft@senecapartners.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUPUGURUPAGAR
Date   Source Headline
4th Jun 20261:34 pmRNSResults of Annual General Meeting voting
30th Apr 202612:12 pmRNSAnnual Report, Notice of AGM and new NAVs
20th Mar 20264:36 pmRNSUnaudited Net asset value (“NAV”) Update
28th Nov 202512:06 pmRNSShare Buy-back and Total Voting Rights
11th Nov 202512:11 pmRNSSecond Interim Dividend on B Shares
21st Oct 20252:40 pmRNSPDMR Shareholding
15th Oct 20254:26 pmRNSUpdated NAV & Ordinary Share Class Dividend
26th Sep 20251:50 pmRNSUnaudited Half-year Report for 6m to 30 June 2025
8th Aug 20254:05 pmRNSIssue of Equity and Total Voting Rights
2nd Jun 20253:15 pmRNSShare Buy-back and Total Voting Rights
22nd May 20251:20 pmRNSResult of AGM
12th May 20254:02 pmRNSInterim Capital Dividend on Ordinary Shares
7th May 20253:04 pmRNSIssue of Equity and Total Voting Rights
29th Apr 20253:58 pmRNSIssue of Supplementary Prospectus
23rd Apr 20254:15 pmRNSFinal results and Notice of AGM
4th Apr 20253:37 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20257:00 amRNSNet Asset Value(s)
19th Mar 20257:00 amRNSInterim Dividend on B Shares
11th Dec 20242:44 pmRNSDirector/PDMR Dealing
11th Dec 20242:39 pmRNSIssue of Equity and Total Voting Rights
15th Nov 20243:15 pmRNSShare Buy-back and Total Voting Rights
14th Nov 20243:32 pmRNSSecond Interim Dividend on B Shares
16th Oct 20247:00 amRNSNet Asset Value(s)
12th Sep 20242:11 pmRNSOffer for Subscription and Prospectus Publication
9th Aug 20243:20 pmGNWIssue of Equity and Total Voting Rights
6th Aug 202410:10 amGNWClosure of Offer for Subscription
25th Jul 20247:00 amGNWHalf-year Report
15th May 202412:16 pmGNWResult of AGM
1st May 20243:34 pmGNWIssue of Equity and Total Voting Rights
1st May 20247:00 amGNWB Share Net Asset Value
22nd Apr 202410:46 amGNWShare Buy-back and Total Voting Rights
5th Apr 202412:44 pmGNWIssue of Equity and Total Voting Rights
4th Apr 20247:00 amGNWNet Asset Value(s)
28th Mar 202412:11 pmGNWIssue of Supplementary Prospectus
22nd Mar 20247:00 amGNWFinal Results, Notice of AGM, Updated NAV
7th Mar 20247:00 amGNWInterim Dividend on B Shares
19th Feb 20244:36 pmGNWDirector Declaration
21st Dec 202312:03 pmGNWIssue of Equity and Total Voting Rights
6th Dec 20233:24 pmGNWDirector/PDMR Dealing
6th Dec 20233:14 pmGNWIssue of Equity and Total Voting Rights
29th Nov 202312:36 pmGNWChange of the Company’s Auditor
20th Nov 20233:20 pmGNWB Share Buy-back and Total Voting Rights
3rd Nov 20237:00 amGNWDividend Declaration
12th Oct 20237:00 amGNWNet Asset Value(s)
11th Oct 20233:39 pmGNWDirectorate Change
24th Aug 20234:18 pmGNWOffer for Subscription and Publication of Prospectus
18th Aug 20235:08 pmGNWIssue of Equity and Total Voting Rights and Capital Reorganisation
2nd Aug 202311:40 amGNWHalf-year Report
30th Jun 20231:58 pmGNWIssue of Equity and Total Voting Rights
20th Jun 20238:50 amGNWShare Buy-back and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.